Prostate Cancer - Results from #680

Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis. July 2, 2024

Reducing Racial Inequalities in Prostate Cancer Treatment: Healthcare Access Barriers. July 2, 2024

Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real-world setting. July 2, 2024

Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D. July 2, 2024

RECOVERY OF SOCIAL CONTINENCE AND SEXUAL FUNCTION IN MEN WITH HIGH-RISK PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: RESULTS FROM A STATEWIDE COLLABORATIVE. July 1, 2024

Updates to Incontinence After Prostate Treatment: AUA/GURS/SUFU Guideline (2024). July 1, 2024

Negative biopsy histology in men with PI-RADS score 5: is it useful PSMA PET/CT evaluation? July 1, 2024

Should systematic prostatic biopsies be discontinued? July 1, 2024

Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer. July 1, 2024

Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer A Systematic Review and Meta-Analysis June 28, 2024

ChatGPT can help guide and empower patients after prostate cancer diagnosis. June 28, 2024

Image-guided multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsy augmented with a sextant versus an extended template random biopsy: Comparison of cancer detection rates, complication and functional outcomes. June 28, 2024

Value of MRI - T2 Mapping to Differentiate Clinically Significant Prostate Cancer. June 28, 2024

Randomized trials of PSA screening. June 28, 2024

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer. June 28, 2024

A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial. June 28, 2024

Prostate Cancer-Specific Lysine 53 Acetylation of Cytochrome c Drives Metabolic Reprogramming and Protects from Apoptosis in Intact Cells. June 28, 2024

Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers June 27, 2024

Prostate Cancer Among Black Men in Canada. June 27, 2024

MRI-guided Cryoablation of Prostate Cancer Lymph Node Metastasis. June 27, 2024

Page 35 of 1436